US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Artesunate for Injection

Reason Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.

Amivas (US), LLC NDC 73607-001-02 D-0002-2022
Class II · Moderate risk Terminated

Hydroquinone USP

Reason Finished product specification did not meet USP specifications.

Monarch PCM, LLC NDC 69367-174-01 D-0855-2021
Class II · Moderate risk Terminated

AirDuo Digihaler 232/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-136-06 D-0025-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 113/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-129-06 D-0024-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 55/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-111-06 D-0023-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 232/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-530-08 D-0022-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 113/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-520-08 D-0021-2022
Class II · Moderate risk Terminated

Sodium Phenylbutyrate Powder

Reason Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.

SigmaPharm Laboratories LLC NDC 42794-086-14 D-0898-2021
Class II · Moderate risk Terminated

Cleaning Solutions Foaming Hand Sanitizer

Reason CGMP Deviations: Use of this product may cause possible infection/ irritation of the skin and/or soft tissues.

Sanitor Corporation D-0018-2022
Class II · Moderate risk Terminated

ceFAZolin

Reason Lack of sterility assurance.

IntegraDose Compounding Services LLC NDC 71139-7087-1 D-0896-2021
Class II · Moderate risk Terminated

Morphine Sulfate Injection

Reason Defective container: Cracked vials leading to lack of sterility assurance

Fresenius Kabi USA LLC NDC 63323-452-01 D-0856-2021
Class II · Moderate risk Terminated

GlipiZIDE Extended-Release Tablets

Reason Failed Dissolution Specifications: results were above specification.

American Health Packaging D-0020-2022
Class II · Moderate risk Terminated

Valproic Acid Oral Solution

Reason CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

American Health Packaging D-0854-2021
Class II · Moderate risk Terminated

Zonisamide 100 mg Capsules

Reason CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

Direct Rx NDC 61919-0775-30 D-0829-2021
Class II · Moderate risk Terminated

Rocuronium Bromide Injection 50mg/5 mL

Reason Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"

Piramal Critical Care, Inc. NDC 66794-0228-41 D-0019-2022
Class II · Moderate risk Terminated

Metoprolol Tartrate Tablets USP 100 mg

Reason Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.

Aurobindo Pharma USA Inc. NDC 65862-064-99 D-0812-2021
Class II · Moderate risk Terminated

Kroger 70% Isopropyl Alcohol First Aid Antiseptic 32 FL OZ

Reason Labeling: Label Mix-Up.The recall has been initiated after receiving one complaint about incorrect labeling.The primary label on the front and back label on some of the bottles have 70% Isopropyl Alcohol affixed to the containers. However, the product inside the bottle is Hydrogen Peroxide, Topical Solution USP with active ingredient Hydrogen Peroxide (stabilized) 3%, 32 FL Ounces

Vi-Jon, Inc. NDC 30142-810-45 D-0799-2021
Class II · Moderate risk Terminated

TheraTears Extra

Reason Lack of Assurance of Sterility

Akorn, Inc. NDC 58790-010-30 D-0717-2022
Class II · Moderate risk Completed

Valproic Acid Oral Solution USP

Reason CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Morton Grove Pharmaceuticals, Inc. D-0816-2021
Class II · Moderate risk Completed

Promethazine With Codeine Oral Solution

Reason CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Morton Grove Pharmaceuticals, Inc. D-0815-2021
Class II · Moderate risk Completed

Promethazine Syrup Plain

Reason CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Morton Grove Pharmaceuticals, Inc. D-0814-2021